Description

NSE suspends trading in partly paid-up equity shares of Solara Active Pharma Sciences Limited (SOLARAPP1) effective April 02, 2026, due to second and final call on shares.

Summary

NSE has notified the suspension of partly paid-up equity shares of Solara Active Pharma Sciences Limited (Symbol: SOLARAPP1, ISIN: IN9624Z01022) from trading with effect from April 02, 2026. The suspension is triggered by the second and final call on the partly paid-up equity shares, in accordance with Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A.

Key Points

  • Trading in SOLARAPP1 (partly paid-up equity shares) will be suspended from April 02, 2026
  • Suspension takes effect after closing hours of trading on April 01, 2026
  • ISIN affected: IN9624Z01022
  • Reason: Second and final call on partly paid-up equity shares
  • Circular issued under Regulation 3.1.2 of NSE Capital Market Trading Regulations Part A
  • Issued by Dhwani Shah, Manager, NSE Listing Department

Regulatory Changes

No new regulatory changes introduced. The suspension is invoked under the existing framework of Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A, which governs suspension of securities from trading upon occurrence of specified corporate events such as a call on partly paid shares.

Compliance Requirements

  • All NSE members are notified and must cease trading in SOLARAPP1 from April 02, 2026
  • Members holding or dealing in partly paid-up equity shares of Solara Active Pharma Sciences Limited must ensure no trades are executed post the suspension effective date
  • Investors holding SOLARAPP1 should be informed of the trading halt and the requirement to respond to the second and final call on shares

Important Dates

  • Circular Date: March 30, 2026
  • Last Trading Day: April 01, 2026 (up to closing hours)
  • Suspension Effective Date: April 02, 2026

Impact Assessment

The suspension directly impacts holders of partly paid-up equity shares (SOLARAPP1) of Solara Active Pharma Sciences Limited, who will be unable to trade these shares on NSE from April 02, 2026. This is a standard procedural action triggered by the second and final call event, after which partly paid shares are expected to be converted to fully paid-up shares upon payment of the call amount. Investors who have not responded to the call should do so promptly to avoid forfeiture. Market impact is limited to holders of this specific partly paid-up instrument and does not affect the fully paid-up equity shares of Solara Active Pharma Sciences Limited.

Impact Justification

Direct trading suspension of a listed security affects all holders of partly paid-up shares of Solara Active Pharma Sciences Limited; requires immediate awareness by traders and investors holding SOLARAPP1.